1-3 of 3
Monet Howard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A with FVIII Inhibitors: Final Analysis

Giancarlo Castaman, Jerzy Windyga, Hazza Alzahrani, Susan Robson, Fabian Sanabria, Monet Howard, Víctor Jiménez-Yuste
Journal: Blood
Blood (2021) 138 (Supplement 1): 344.
https://doi.org/10.1182/blood-2021-145890
Published: 2021
Journal Articles

Evaluation of the Safety of Emicizumab Prophylaxis in Persons with Hemophilia A: An Updated Summary of Thrombotic Events and Thrombotic Microangiopathies

Monet Howard, Derrick McKinley, Fabian Sanabria, Richard H. Ko, Francis Nissen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3186.
https://doi.org/10.1182/blood-2021-146147
Published: 2021
Journal Articles

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Clinical Trials & Observations
Michael U. Callaghan, Claude Negrier, Ido Paz-Priel, Tiffany Chang, Sammy Chebon, Michaela Lehle, Johnny Mahlangu, Guy Young, Rebecca Kruse-Jarres, Maria Elisa Mancuso, Markus Niggli, Monet Howard, Nives Selak Bienz, Midori Shima, Victor Jiménez-Yuste, Christophe Schmitt, Elina Asikanius, Gallia G. Levy, Steven W. Pipe, Johannes Oldenburg
Journal: Blood
Blood (2021) 137 (16): 2231–2242.
https://doi.org/10.1182/blood.2020009217
Published: 2021
Includes: Supplemental data